The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal ...

Late Thursday, the US Food and Drug Administration revealed it is taking a ground-breaking step to advance public health by ...

Human-Based Lab Models: The FDA will promote the use of lab-grown human “organoids” and organ-on-a-chip systems that mimic ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, ...

But Youle’s dismissal, along with 10 others at the NIH’s National Institute of Neurological Disorders and Stroke, underscores ...

We recently published a list of Traders Heavily Sold Down These 10 Stocks on Thursday. In this article, we are going to take ...

RedChip Companies will air interviews with Bullfrog AI Holdings, Inc. (Nasdaq:BFRG) and Connect Biopharma Holdings Limited (Nasdaq:CNTB) and on the RedChip Small Stocks, Big Money™ show, a sponsored ...

Shares of Charles River Laboratories International, Inc. (CRL) traded over 3% lower on Friday morning after the U.S. Food and ...

Shares of Recursion Pharmaceuticals Inc. rocketed over 19% in Thursday's after-hours trading, boosting retail investor sentiment, after the U.S. health regulator unveiled plans to modernize drug ...

The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...